GENERATIONAL EQUITY

CENTRAL OCTOBER 25

Issue link: http://deals.uberflip.com/i/1539905

Contents of this Issue

Navigation

Page 89 of 221

REVENUE / EBITDA $1.7M $259K 2024 REVENUE 2024 EBITDA $1.9M $303K 2025 REVENUE 2025 EBITDA (PROJ) (PROJ) BUSINESS STATS Founded in 2011 Fully Remote Opera ons 13 Independent Contractors 93% Rate of Repeat Business High Profile Customers 30% Domes c Markets 70% Interna onal Markets CUSTOMERS Customer A Customer B Customer C Customer D Customer E Julie Sandoval 9% 7% 6% 5% 4% Senior Managing Director E: jsandoval@generational.com D: 678-646-6704 BUSINESS HIGHLIGHTS The Company is a provider of independent, postgraduate medical educa on for clinicians globally. The Company specializes in designing, managing, and distribu ng con nuing medical educa on (CME) content that supports the launch and lifecycle of new pharmaceu cal therapies, with a focus on oncology and cardiometabolic diseases. The Company's core offering is its Medical Educa on Programs, which account for 100% of revenue. These include live events, on-demand content, and informa onal products, such as scientific reports, newsle ers, and slide decks tailored to specific therapeu c areas. 2024 CUSTOMER MARKETS INVESTMENT APPEAL Oncolo 60% • Interna onal Reach: The Company maintains a proprietary database of over 200,000 physicians worldwide, segmented by specialty and country. This database enables marke ng of CME programs to specialty and region-specific clinicians giving the Company a competitive advantage over U.S.-based providers entering the global space. The Company abides by the European Union general data protection regulation (GDPR) which is the strongest privacy and security law in the world. • Outstanding Growth Opportuni es: The Company is actively expanding its offerings in high growth therapeutic areas such as obesity and breast cancer. It is also pursuing strategic initiatives to repurpose U.S.-based educa on for interna onal markets, supported by a strong pipeline of pending business and renewed operational momentum. • Superior Name and Reputa on: The Company is recognized globally for its high-quality, independent medical education programs and long-standing partnerships with key opinion leaders, leading institutions and associations. Its reputation is built on scientific integrity, international reach, and consistent delivery of specialty-focused content. THE & ADVISOR INVESTMENT BANK OF THE YEAR 2016 • 2017 -2018 -2022 • 2024 Genera onal Equity 3400 North Central Expressway, Suite 100 Richardson, TX, 75080 T. 972-232-1121 F. 972-392-8564 DISCLAIMER: All information contained in this document has been provided by the subject company to Generational Equity and while believed to be correct has not been verified. Accordingly, Generational Equity makes no representations or warranties as to the accuracy and truthfulness of such information. The recipient hereof acknowledges that Generational Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Genera• tional Equity of this document. At all times Generational Equity and/or its affiliate network members are agents for the seller and not for the buyer. Genera onal Equi s fees are paid by the seller.

Articles in this issue

Links on this page

Archives of this issue

view archives of GENERATIONAL EQUITY - CENTRAL OCTOBER 25